文献速递泌尿生殖腹部MR

多参数MRI靶向活检与系统活检对筛状结构及导管内癌前列腺癌检出率的比较

Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
PubMed 文献 · Radiology · 2024-01-01

本研究为一项前瞻性随机对照试验的二次分析,纳入5个中心2017年4月至2019年11月临床怀疑前列腺癌的男性,比较MRI靶向活检与系统活检对筛状结构/导管内癌(Cr/IDC)组织学模式的检出情况。结果显示,MRI靶向活检组Cr/IDC检出率高于系统活检组(25% vs 16%,P=.01),但两组在临床显著前列腺癌的平均癌核心长度、表观扩散系数及动态对比增强阳性率上无显著差异。

要点

  • MRI靶向活检对筛状结构/导管内癌的检出率高于系统活检(25% vs 16%,P=.01)。
  • Cr/IDC阳性组织学模式整体平均癌核心长度大于Cr/IDC阴性临床显著前列腺癌(11.1 mm vs 9.2 mm,P=.009)。
  • MRI靶向活检组中,有无Cr/IDC病变者在平均癌核心长度、ADC值及DCE阳性率上无显著差异。

核心结论

  • 与系统活检相比,MRI靶向活检提高了筛状结构/导管内癌组织学模式的检出率。

研究设计与样本

  • 前瞻性随机对照试验的二次分析,5个中心,纳入2017年4月至2019年11月临床怀疑前列腺癌的男性,1:1随机分为MRI组或系统活检组;MRI组对PI-RADS评分≥3者行靶向活检;采用广义线性混合模型比较Cr/IDC模式。

诊断标准与关键数值

  • 系统活检组Cr/IDC前列腺癌检出为196例活检中31例(16%),MRI靶向活检组为132例活检中33例(25%),P=.01。
  • MRI组中,有无Cr/IDC的临床显著前列腺癌平均癌核心长度分别为11.3 mm±4.4与9.7 mm±4.5(P=.09)。
  • MRI组中,有无Cr/IDC的临床显著前列腺癌平均表观扩散系数分别为685 µm2/sec±178与746 µm2/sec±245(P=.52)。
  • MRI组中,有无Cr/IDC的临床显著前列腺癌动态对比增强阳性分别为27例(82%)与37例(90%)(P=.33)。
  • Cr/IDC阳性组织学模式整体平均癌核心长度为11.1 mm±4.4,Cr/IDC阴性临床显著前列腺癌为9.2 mm±4.1(P=.009)。

临床应用与阅片要点

  • 对于临床怀疑前列腺癌且PI-RADS评分≥3的活检初治男性,MRI靶向活检较系统活检更易检出筛状结构/导管内癌组织学模式。
  • Cr/IDC阳性组织学模式与更大的平均癌核心长度相关(11.1 mm vs 9.2 mm,P=.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Intraductal carcinoma (IDC) and invasive cribriform (Cr) subtypes of prostate cancer (PCa) are an indication of aggressiveness, but the evidence regarding whether MRI can be used to detect Cr/IDC-pattern PCa is contradictory. Purpose To compare the detection of Cr/IDC-pattern PCa at multiparametric MRI (mpMRI)-targeted biopsy versus systematic biopsy in biopsy-naive men at risk for PCa. Materials and Methods This study was a secondary analysis of a prospective randomized controlled trial that recruited participants with a clinical suspicion of PCa between April 2017 and November 2019 at five centers. Participants were randomized 1:1 to either the MRI arm or the systematic biopsy arm. Targeted biopsy was performed in participants with a Prostate Imaging Reporting and Data System score of at least 3. MRI features were recorded, and biopsy slides and prostatectomy specimens were reviewed for the presence or absence of Cr/IDC histologic patterns. Comparison of Cr/IDC patterns was performed using generalized linear mixed modeling. Results A total of 453 participants were enrolled, with 226 in the systematic biopsy arm (median age, 65 years [IQR, 59-70 years]; 196 biopsies available for assessment) and 227 in the mpMRI-targeted biopsy arm (median age, 67 years [IQR, 60-72 years]; 132 biopsies available for assessment). Identification of Cr/IDC PCa was lower in the systematic biopsy arm compared with the mpMRI arm (31 of 196 biopsies [16%] vs 33 of 132 biopsies [25%]; P = .01). No evidence of a difference in mean cancer core length (CCL) (11.3 mm ± 4.4 vs 9.7 mm ± 4.5; P = .09), apparent diffusion coefficient (685 µm2/sec ± 178 vs 746 µm2/sec ± 245; P = .52), or dynamic contrast-enhanced positivity (27 [82%] vs 37 [90%]; P = .33) for clinically significant PCa (csPCa) was observed between participants with or without Cr/IDC disease in the MRI arm. Cr/IDC-positive histologic patterns overall had a higher mean CCL compared with Cr/IDC-negative csPCa (11.1 mm ± 4.4 vs 9.2 mm ± 4.1; P = .009). Conclusion MRI-targeted biopsy showed increased detection of Cr/IDC histologic patterns compared with systematic biopsy. Clinical trial registration no. NCT02936258 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Scialpi and Martorana in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ghai S, Klotz L, Pond GR, et al. Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer. Radiology. 2024. PMID: 39012252. doi:10.1148/radiol.231948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。